NASDAQ:PAHC - Get Free Report )'s share price reached a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $17.42 and last traded at $17.36, with a volume of 47998 shares changing hands. The stock had previously closed at $16.77.
Get Phibro Animal Health alerts:
Sign Up
Wall Street Analyst Weigh In Separately, StockNews.com raised Phibro Animal Health from a "hold" rating to a "buy" rating in a report on Tuesday, April 9th.
Check Out Our Latest Stock Report on PAHC
Phibro Animal Health Price Performance The company has a market capitalization of $695.79 million, a price-to-earnings ratio of 46.58, a price-to-earnings-growth ratio of 6.30 and a beta of 0.63. The company has a 50-day moving average price of $13.39 and a 200-day moving average price of $12.00. The company has a debt-to-equity ratio of 1.66, a quick ratio of 1.60 and a current ratio of 3.12.
Phibro Animal Health (NASDAQ:PAHC - Get Free Report ) last posted its earnings results on Wednesday, February 7th. The company reported $0.33 earnings per share for the quarter, topping the consensus estimate of $0.27 by $0.06. Phibro Animal Health had a net margin of 1.51% and a return on equity of 16.67%. The company had revenue of $249.90 million for the quarter, compared to analyst estimates of $242.91 million. On average, equities research analysts expect that Phibro Animal Health Co. will post 1.12 EPS for the current fiscal year.
Institutional Investors Weigh In On Phibro Animal Health Several large investors have recently modified their holdings of the business. Barclays PLC increased its stake in Phibro Animal Health by 59.8% during the 3rd quarter. Barclays PLC now owns 35,638 shares of the company's stock worth $456,000 after purchasing an additional 13,332 shares in the last quarter. Trexquant Investment LP lifted its position in Phibro Animal Health by 143.6% in the 3rd quarter. Trexquant Investment LP now owns 35,872 shares of the company's stock valued at $458,000 after acquiring an additional 21,147 shares in the last quarter. Brandes Investment Partners LP boosted its stake in Phibro Animal Health by 38.5% in the 3rd quarter. Brandes Investment Partners LP now owns 1,873,300 shares of the company's stock worth $23,922,000 after purchasing an additional 520,697 shares during the period. China Universal Asset Management Co. Ltd. increased its holdings in Phibro Animal Health by 358.6% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 2,357 shares of the company's stock worth $27,000 after purchasing an additional 1,843 shares in the last quarter. Finally, New York State Common Retirement Fund lifted its holdings in shares of Phibro Animal Health by 20.9% in the third quarter. New York State Common Retirement Fund now owns 69,944 shares of the company's stock valued at $893,000 after purchasing an additional 12,110 shares in the last quarter. 99.34% of the stock is currently owned by institutional investors.
About Phibro Animal Health (
Get Free Report )
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Read More This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Phibro Animal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.
While Phibro Animal Health currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
